Top Industry Leaders in the Chikungunya Fever Market
Latest Chikungunya Fever Companies Update:
Valneva Leading the way with their approved Ixchiq vaccine, which offers protection against both chikungunya and Mayaro viruses.
Bharat Biotech International Ltd, Indian company developing a chikungunya vaccine candidate currently in Phase 3 clinical trials.
Valneva and AbiVax Collaborating on developing a combination therapy targeting both chikungunya and dengue viruses, two mosquito-borne diseases with overlapping symptoms.
Novartis Focuses on developing therapeutics for chikungunya-associated joint pain and inflammation.
Etubics Corp. Developing rapid diagnostic tests for early detection of chikungunya infection.
List of Chikungunya Fever companies in the market
- Quest Diagnostics Incorporated. (U.S.A)
- Alere. (U.S.A)
- Genome Diagnostics Pvt. Ltd. (India)
- Altona Diagnostics (Europe)
- Bio-Rad Laboratories Inc. (U.S.A)
- Sanat Products Ltd. (India)
- Taj Pharmaceuticals Limited. (India)
- Etubics Corporation (U.S.A)